Home/Filings/4/0001104659-22-063971
4//SEC Filing

Votruba Michal 4

Accession 0001104659-22-063971

CIK 0001720893other

Filed

May 22, 8:00 PM ET

Accepted

May 23, 6:48 PM ET

Size

8.1 KB

Accession

0001104659-22-063971

Insider Transaction Report

Form 4
Period: 2022-05-19
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-05-19+17,00017,000 total
    Exercise: $13.24Exp: 2032-05-19Common Stock (17,000 underlying)
  • Other

    Stock Option (Right to Buy)

    2022-05-1917,0000 total
    Exercise: $13.24Exp: 2032-05-19Common Stock (17,000 underlying)
Footnotes (2)
  • [F1]The Reporting Person immediately and automatically assigned these stock options to RSJ Investments SICAV a.s. acting in respect of its sub-fund RSJ Gradus podfund ("RSJ") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ. The Reporting Person does not beneficially own any of the securities reported herein.
  • [F2]The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date.

Issuer

BioXcel Therapeutics, Inc.

CIK 0001720893

Entity typeother

Related Parties

1
  • filerCIK 0001653967

Filing Metadata

Form type
4
Filed
May 22, 8:00 PM ET
Accepted
May 23, 6:48 PM ET
Size
8.1 KB